Tocotrienol: The natural vitamin E to defend the nervous system?

Annals of the New York Academy of Sciences

Volumn 1031, Issue , 2004, Pages 127-142

  Sen, Chandan K ^a   Khanna, Savita ^a   Roy, Sashwati ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Antioxidant; Glutamate; Neuroprotection; Neurotoxicity; Nutrient

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; APOLIPOPROTEIN B; CHOLESTEROL; DNA; GLUTAMIC ACID; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE P60;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN; BREAST CANCER; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DIET SUPPLEMENTATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID PEROXIDATION; LIVER TUMOR; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN;

GLYCINE MAX; HORDEUM VULGARE SUBSP. VULGARE; ZEA MAYS;

EID: 14944373280     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1331.013     Document Type: Conference Paper

References (120)

1. MULLER, D.P. & M.A. GOSS-SAMPSON. 1989. Role of vitamin E in neural tissue. Ann. N.Y. Acad. Sci. 570: 146-155.
2. MULLER, D.P. & M.A. GOSS-SAMPSON. 1990. Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. Crit. Rev. Neurobiol. 5: 239-263.
3. FLOYD, R.A. 1999. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222: 236-245.
4. REITER, R.J. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9: 526-533.
5. SCHULZ, J.B., et al. 2000. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267: 4904-4911.
6. ZHANG, Y., V.L. DAWSON & T.M. DAWSON. 2000. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7: 240-250.
7. VATASSERY, G.T., S. FAHN & M.A. KUSKOWSKI. 1998. alpha-Tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study: Parkinson Study Group. Neurology 50: 1900-1902.
8. VATASSERY, G.T. 1998. Vitamin E and other endogenous antioxidants in the central nervous system. Geriatrics 53(Suppl. 1): S25-S27.
9. TRABER, M.G. & H. SIES. 1996. Vitamin E in humans: demand and delivery. Annu. Rev. Nutr. 16: 321-347.
10. TRABER, M.G. & L. PACKER. 1995. Vitamin E: beyond antioxidant function. Am. J. Clin. Nutr. 62: 1501S-1509S.
11. SEN, C.K. et al. 2000. Molecular basis of vitamin E action: tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 275: 13049-13055.
12. ADACHI, H. & N. ISHII. 2000. Effects of tocotrienols on lifespan and protein carbonylation in Caenorhabditis elegans. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 55: B280-B285.
13. QURESHI, A.A. et al. 2000. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J. Agric. Food Chem. 48: 3130-3140.
14. MCINTYRE, B.S. et al. 2000. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc. Soc. Exp. Biol. Med. 224: 292-301.
15. MCINTYRE, B.S. et al. 2000. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35: 171-180.
16. YU, W. et al. 1999. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer 33: 26-32.
17. THERIAULT, A. et al. 1999. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler, Thromb. Vasc. Biol. 19: 704-712.
18. NEWAZ, M.A. & N.N. NAWAL. 1999. Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). Clin. Exp. Hypert. (New York) 21: 1297-1313.
19. MO, H. & C.E. ELSON. 1999. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J. Nutr. 129: 804-813.
20. MENSINK, R.P. et al. 1999. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am. J. Clin. Nutr. 69: 213-219.
21. KAKU, S. et al. 1999. Effect of dietary antioxidants on serum lipid contents and immunoglobulin productivity of lymphocytes in Sprague-Dawley rats. Biosci. Biotechnol. Biochem. 63: 575-576.
22. GU, J.Y. et al. 1999. Dietary effect of tocopherols and tocotrienols on the immune function of spleen and mesenteric lymph node lymphocytes in Brown Norway rats. Biosci. Biotechnol. Biochem. 63: 1697-1702.
23. NESARETNAM, K. et al. 1998. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33: 461-469.
24. HOSOMI, A. et al. 1997. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409: 105-108.
25. GUTHRIE, N. et al. 1997. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127: 544S-548S.
26. HE, L. et al. 1997. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J. Nutr. 127: 668-674.
27. IKEDA, I. et al. 1996. Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats. Int. J. Vit. Nutr. Res. 66: 217-221.
28. TOMEO, A.C. et al. 1995. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30: 1179-1183.
29. QURESHI, A.A. et al. 1995. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30: 1171-1177.
30. NESARETNAM, K. et al. 1995. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30: 1139-1143.
31. KAMAT, J.P. & T.P. DEVASAGAYAM. 1995. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci. Lett. 195: 179-182.
32. ELSON, C.E. & A.A. QURESHI. 1995. Coupling the cholesterol- and tumor-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Prostag. Leukotr. Essent. Fatty Acids 52: 205-207.
33. PEARCE, B.C. et al. 1994. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J. Med. Chem. 37: 526-541.
34. GOH, S.H. et al. 1994. Inhibition of tumour promotion by various palm-oil tocotrienols. Int. J. Cancer 57: 529-531.
35. WATKINS, T. et al. 1993. gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 28: 1113-1118.
36. SUZUKI, Y.J. et al. 1993. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 32: 10692-10699.
37. SUARNA, C. et al. 1993. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim. Biophys. Acta 1166: 163-170.
38. RAHMAT, A. et al. 1993. Long-term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats. Nutrition 9: 229-232.
39. PARKER, R.A. et al. 1993. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3- methylglutaryl-coenzyme A reductase. J. Biol. Chem. 268: 11230-11238.
40. PEARCE, B.C. et al. 1992. Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 35: 3595-3606.
41. KOBA, K. et al. 1992. Effects of alpha-tocopherol and tocotrienols on blood pressure and linoleic acid metabolism in the spontaneously hypertensive rat (SHR). Biosci. Biotechnol. Biochem. 56: 1420-1423.
42. KAGAN, V.E. et al. 1992. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33: 385-397.
43. SERBINOVA, E. et al. 1991. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 10: 263-275.
44. QURESHI, A.A. et al. 1991. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am. J. Clin. Nutr. 53: 1021S-1026S.
45. TAN, D.T. et al. 1991. Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans. Am. J. Clin. Nutr. 53: 1027S-1030S.
46. QURESHI, A.A. et al. 1991. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am. J. Clin. Nutr. 53: 1042S-1046S.
47. NGAH, W.Z. et al. 1991. Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats. Am. J. Clin. Nutr. 53: 1076S-1081S.
48. GOULD, M.N. et al. 1991. A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors. Am. J. Clin. Nutr. 53: 1068S-1070S.
49. SUNDRAM, K. et al. 1989. Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz(a)anthracene. Cancer Res. 49: 1447-1451.
50. KOMIYAMA, K. et al. 1989. Studies on the biological activity of tocotrienols. Chem. Pharmaceut. Bull. 37: 1369-1371.
51. QURESHI, A.A. et al. 1986. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J. Biol. Chem. 261: 10544-10550.
52. SERBINOVA, E.A. & L. PACKER. 1994. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Methods Enzymol. 234: 354-366.
53. BANNAI, S. et al. 1984. Amino acid transport systems [letter]. Nature 311: 308.
54. SEN, C.K. 1997. Nutritional biochemistry of cellular glutathione. J. Nutr. Biochem. 8: 660-672.
55. SATO, H. et al. 1998. Induction of cystine transport via system x-c and maintenance of intracellular glutathione levels in pancreatic acinar and islet cell lines. Biochim. Biophys. Acta 1414: 85-94.
56. DROGE, W., H.P. ECK & S. MIHM. 1992. HIV-induced cysteine deficiency and T-cell dysfunction: a rationale for treatment with N-acetylcysteine. Immunol. Today 13: 211-214.
57. DROGE, W. et al. 1994. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8: 1131-1138.
58. SEN, C.K. et al. 1997. Regulation of cellular thiols in human lymphocytes by alpha-lipoic acid: a flow cytometric analysis. Free Radic. Biol. Med. 22: 1241-1257.
59. HAN, D. et al. 1997. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6: 321-338.
60. SEN, C.K., S. ROY & L. PACKER. 1998. Oxidants and antioxidants in glutamate induced cytotoxicity. In Biological Oxidants and Antioxidants: Molecular Mechanisms and Health Effects. L. Packer & A.S. Ong, Eds.: 5-13. AOCS Press. Champaign, IL.
61. COYLE, J.T. & P. PUTTFARCKEN. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
62. CHOI, D.W. 1990. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metab. Rev. 2: 105-147.
63. TAN, S. et al. 1998. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141: 1423-1432.
64. MURPHY, T.H., R.L. SCHNAAR & J.T. COYLE. 1990. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4: 1624-1633.
65. KATO, S. et al. 1992. A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion. Neuroscience 48: 903-914.
66. HAN, D. et al. 1997. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am. J. Physiol. 273: R1771-R1778.
67. PEREIRA, C.M. & C.R. OLIVEIRA. 1997. Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress. Free Radic. Biol. Med. 23: 637-647.
68. FROISSARD, P., H. MONROCQ & D. DUVAL. 1997. Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur. J. Pharmacol. 326: 93-99.
69. OKA, A. et al. 1993. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 13: 1441-1453.
70. SCHUBERT, D., H. KIMURA & P. MAHER. 1992. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. USA 89: 8264-8267.
71. LI, Y., P. MAHER & D. SCHUBERT. 1997. Requirement for cGMP in nerve cell death caused by glutathione depletion. J. Cell. Biol. 139: 1317-1324.
72. LI, Y., P. MAHER & D. SCHUBERT. 1997. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19: 453-463.
73. LI, Y., P. MAHER & D. SCHUBERT. 1998. Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc. Natl. Acad. Sci. USA 95: 7748-7753.
74. SAGARA, Y. et al. 1998. Cellular mechanisms of resistance to chronic oxidative stress. Free Radic. Biol. Med. 24: 1375-1389.
75. MAHER, P. & D. SCHUBERT. 2000. Signaling by reactive oxygen species in the nervous system. Cell. Mol. Life Sci. 57: 1287-1305.
76. POST, A., F. HOLSBOER & C. BEHL. 1998. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. J. Neurosci. 18: 8236-8246.
77. BEHL, C. 1998. Effects of glucocorticoids on oxidative stress-induced hippocampal cell death: implications for the pathogenesis of Alzheimer's disease. Exp. Gerontol. 33: 689-696.
78. SATOH, T. et al. 2000. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett. 288: 163-166.
79. VEDDER, H. et al. 2000. Characterization of the neuroprotective effects of estrogens on hydrogen peroxide-induced cell death in hippocampal HT22 cells: time and dose dependency. Exp. Clin. Endocrinol. Diabetes 108: 120-127.
80. STANCIU, M. et al. 2000. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275: 12200-12206.
81. XIAO, N. et al. 1999. Geldanamycin provides posttreatment protection against glutamate-induced oxidative toxicity in a mouse hippocampal cell line. J. Neurochem. 72: 95-101.
82. MORIMOTO, B.H. & D.E. KOSHLAND, JR. 1990. Excitatory amino acid uptake and N-methyl-D-aspartate-mediated secretion in a neural cell line. Proc. Natl. Acad. Sci. USA 87: 3518-3521.
83. TIROSH, O. et al. 1999. Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue. Free Radic. Biol. Med. 26: 1418-1426.
84. O'BYRNE, D. et al. 1999. Supplementation with alpha-tocotrienyl acetate enhances LDL oxidative resistance without lowering serum cholesterol in hypercholesterolemic humans. FASEB J. 13: A536.
85. O'BYRNE, D. et al. 2000. Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic. Biol. Med. 29: 834-845.
86. KHANNA, S. et al. 2003. Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J. Biol. Chem. Epub Aug 13.
87. BRUGGE, J.S. et al. 1985. Neurones express high levels of a structurally modified, activated form of pp60c-src. Nature 316: 554-557.
88. LAVOIE, J.N. et al. 2000. Adenovirus E4 open reading frame 4-induced apoptosis involves dysregulation of Src family kinases. J. Cell Biol. 150: 1037-1056.
89. IMPEY, S., K. OBRIETAN & D. R. STORM. 1999. Making new connections: role of ERK/ MAP kinase signaling in neuronal plasticity. Neuron 23: 11-14.
90. XIA, Z. et al. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
91. SEGAL, R.A. & M.E. GREENBERG. 1996. Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19: 463-489.
92. BOULTON, T.G. et al. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675.
93. CREEDON, D.J., E.M. JOHNSON & J.C. LAWRENCE. 1996. Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J. Biol. Chem. 271: 20713-20718.
94. MURRAY, B. et al. 1998. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. Natl. Acad. Sci. USA 95: 11975-11980.
95. RUNDEN, E. et al. 1998. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18: 7196-7305.
96. BHAT, N.R. & P. ZHANG. 1999. Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72: 112-119.
97. KUMMER, J.L., P.K. RAO & K.A. HEIDENREICH. 1997. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272: 20490-20494.
98. ALESSANDRINI, A. et al. 1999. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 96: 12866-12869.
99. SUGDEN, P.H. & A. CLERK. 1997. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell. Signal. 9: 337-351.
100. AIKAWA, R. et al. 1997. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100: 1813-1821.
101. BENARD, O., Z. NAOR & R. SEGER. 2001. Role of dynamin, Src and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone. J. Biol. Chem. 276: 4554-4563.
102. DAULHAC, L. et al. 1999. Src-family tyrosine kinases in activation of ERK-1 and p85/ p110-phosphatidylinositol 3-kinase by G/CCKB receptors. J. Biol. Chem. 274: 20657-20663.
103. MIGLIACCIO, A. et al. 1998. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17: 2008-2018.
104. DRINGEN, R., J.M. GUTTERER & J. HIRRLINGER. 2000. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267: 4912-4916.
105. BAINS, J.S. & C.A. SHAW. 1997. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 25: 335-358.
106. LEPLEY, R.A., D.T. MUSKARDIN & F.A. FITZPATRICK. 1996. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271: 6179-6184.
107. CAPODICI, C. et al. 1998. Integrin-dependent homotypic adhesion of neutrophils: arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase- dependent pathway. J. Clin. Invest. 102: 165-175.
108. SZEKERES, C.K. et al. 2000. Eicosanoid activation of extracellular signal-regulated kinase 1/2 in human epidermoid carcinoma cells. J. Biol. Chem. 275: 38831-38841.
109. TRAN, K., P.R. PROULX & A.C. CHAN. 1994. Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity. Biochim. Biophys. Acta 1212: 193-202.
110. STEPHENSON, D.T. et al. 1996. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3: 51-63.
111. KANFER, J.N. et al. 1996. Phospholipid metabolism in Alzheimer's disease and in a human cholinergic cell. J. Lipid Med. Cell Signal. 14: 361-363.
112. ERIN, A.N. et al. 1986. Stabilization of synaptic membranes by alpha-tocopherol against the damaging action of phospholipases: possible mechanism of biological action of vitamin E. Brain Res. 398: 85-90.
113. PODDA, M. et al. 1996. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. J. Lipid Res. 37: 893-901.
114. THIELE, J.J. et al. 1997. Ozone depletes tocopherols and tocotrienols topically applied to rnurine skin. FEES Lett. 401: 167-170.
115. WEBER, C. et al. 1997. Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV irradiation. Free Radic. Biol. Med. 22: 761-769.
116. NESARETNAM, K. et al. 1993. Influence of palm oil or its tocotrienol-rich fraction on the lipid peroxidation potential of rat liver mitochondria and microsomes. Biochem. Mol. Biol. Int. 30: 159-167.
117. ROY, S. et al. 2002. Simultaneous detection of tocopherols and tocotrienols in biological samples using HPLC-coulometric electrode array. Methods Enzymol. 352: 326-332.
118. ROY, S. et al. 2002. Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett. 530: 17-23.
119. RICCIARELLI, R. et al. 1998. alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 334: 243-249.
120. LIEBECQ, C. 1992. Biochemical Nomenclature and Related Documents. IUPAC-IUBMB Joint Commission on Biochemical Nomenclature and Nomenclature Commission of IUBMB347.